Market Movers Today: Chegg Inc (CHGG), Helios and Matheson Analytics Inc (HMNY), Blue Apron Holdings Inc (APRN), and More

Chegg Inc (NYSE:CHGG) (The Motley Fool)
What happened: shares of Chegg Inc. (NYSE:CHGG) jumped on Tuesday after the connected learning platform provider reported its fourth-quarter results. The company beat analyst estimates for both revenue and earnings, pushing the stock up about 15.5% by 12:10 p.m. EST. So what: Chegg reported fourth-quarter revenue of $73.5 million, up 17% year over year and about $2.9 million higher than the average analyst estimate.

Helios and Matheson Analytics Inc (NASDAQ:HMNY) (MarketWatch)
Shares of MoviePass majority owner Helios & Matheson Analytics Inc. HMNY, -30.35% were down more than 30% in premarket trade on Tuesday after the data company announced a $105 million public equity offering. The offering includes 7,425,000 Series A units, each made up of one common share and a warrant to buy an additional share. The offering also includes 11,675,000 Series B units, each including a Series B pre-funded warrant to by common share and a Series A warrant to buy shares.

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart

bluebay/Shutterstock.com

Blue Apron Holdings Inc (NYSE:APRN) (CNBC)
Shares of Blue Apron spiked Tuesday after the company posted a smaller-than-expected fourth-quarter loss, helped by improvements at its fulfillment center in New Jersey. The stock was up 6 percent. Early in Tuesday’s session, it had risen nearly 27 percent. Blue Apron has been struggling to overcome well-publicized operational issues that have dragged its stock down more than 66 percent since it started trading in late June. Shares have slipped from $11 to just under $4 during that period. The meal kit company said increased automation bolstered productivity in the Linden, New Jersey, center and brought it in-line with its counterparts in California and Texas.

WMIH Corp (NASDAQ:WMIH) (Benzinga)
WMIH Corp. shares surged 62.1 percent to $1.29. The insurance company agreed to merge with Nationstar Mortgage Holdings Inc. Nationstar shareholders could chose to receive $18.00 in cash or 12.7793 of WMIH common stock for each share owned. Nationstar shareholders will own around 36 percent of the combined entity with WMIH shareholders owning the remaining 64 percent.

Under Armour Inc (NYSE:UA) (MarketWatch)
Under Armour Inc. shares UA, +13.28% UAA, +14.85% surged 13% in premarket trade Tuesday, after the company posted stronger-than-expected revenue for the fourth quarter. The company said it had a net loss of $87.9 million, or 20 cents a share, in the quarter, after earnings of $103.2 million, or 23 cents a share, in the year-earlier period. Adjusting for a one-time tax charge and restructuring costs, the company had breakeven EPS, matching the FactSet consensus. Revenue came to $1.4 billion, beating the FactSet consensus of $1.3 billion.

Generac Holdings Inc. (NYSE:GNRC) (CNBC)
Generac – The maker of power generators earned an adjusted $1.37 per share for the fourth quarter, beating the $1.19 a share consensus estimate. Revenue also topped forecasts, with shipments of home standby generators near record levels thanks to elevated power outage activity.

Henry Schein, Inc. (NASDAQ:HSIC) (The Motley Fool)
What happened: Shares of Henry Schein (NASDAQ:HSIC), a maker of dental and veterinary products, fell as much as 13% in early morning trading on Tuesday as a result of accusations leveled against the company for breaking antitrust rules. The stock has since recovered but is still down about 10% as of 11:05 a.m. EST. So what: On Monday night, it was reported that the Federal Trade Commission has filed a complaint against the three largest U.S. dental supply companies in the country — Benco Dental Supply, Henry Schein, and Patterson Companies (NASDAQ:PDCO) — for running afoul of antitrust law.

Dare Bioscience Inc (NASDAQ:DARE) (Benzinga)
Dare Bioscience Inc shares tumbled 39.8 percent to $1.68. Dare Bioscience priced 5 million common share and warrants to buy up to 3.5 million common shares at $3 per share.

AmerisourceBergen Corp. (NYSE:ABC) (Reuters)
(Reuters) – Walgreens’ potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, analysts said. A deal would not be a surprise, but analysts noted that it might cost Walgreens Boots Alliance opportunities down the line as the company tries to keep pace with rival CVS Health Corp, which is set to buy health insurer Aetna Inc, and possibly go up against Amazon.com. AmerisourceBergen shares were up 8.7 percent in midday trading, while Walgreens shares were little changed.